Literature DB >> 24248691

Sex difference in myelodysplastic syndrome survival and balance in randomized clinical trials.

Tomas Radivoyevitch1, Yogen Saunthararajah.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24248691     DOI: 10.1200/JCO.2013.52.5980

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  SLC7A5 act as a potential leukemic transformation target gene in myelodysplastic syndrome.

Authors:  Yan Ma; Jing Song; Bobin Chen; Xiaoping Xu; Guowei Lin
Journal:  Oncotarget       Date:  2016-02-09

2.  Cytogenetic features in primary myelodysplastic syndrome Egyptian patients.

Authors:  Yasser Elnahass; Lamiaa Youssif
Journal:  J Adv Res       Date:  2018-02-07       Impact factor: 10.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.